EP
Eversept Partners Portfolio holdings
AUM
$1.31B
1-Year Est. Return
41.01%
1 Year Est. Return
+41.01%
AUM
$1.31B
AUM Growth
+$313M
(+32%)
Holding
98
Top Buys
| 1 | +$81.3M | |
| 2 | +$51.2M | |
| 3 | +$36.2M | |
| 4 |
Danaher
DHR
|
+$15M |
| 5 |
Insulet
PODD
|
+$14.1M |
Top Sells
| 1 | +$44.5M | |
| 2 | +$21.3M | |
| 3 | +$15.4M | |
| 4 |
Protagonist Therapeutics
PTGX
|
+$15.3M |
| 5 |
Mirum Pharmaceuticals
MIRM
|
+$13.4M |
Sector Composition
| 1 | Healthcare | 99.96% |
| 2 | Financials | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$20.8B
| $106M | 7.32% |
253,220
+193,854
|
|
||
2
GSK
GSK
$97.1B
| $91.5M | 6.31% |
2,120,446
-121,942
|
|
||
3
Natera
NTRA
$33.1B
| $83.6M | 5.76% |
519,644
-276,731
|
|
||
4
Vera Therapeutics
VERA
$2.84B
| $81.6M | 5.62% |
2,807,836
+424,781
|
|
||
5
Syndax Pharmaceuticals
SNDX
$1.7B
| $53.3M | 3.68% |
3,467,314
-598,041
|
|
||
6
Vaxcyte
PCVX
$5.76B
| $51.2M | 3.53% |
1,421,983
+123,469
|
|
||
7
uniQure
QURE
$1.29B
| $51.2M | 3.53% |
+877,373
|
|
||
8
HCA Healthcare
HCA
$110B
| $47.6M | 3.28% |
111,700
+11,717
|
|
||
9
Viridian Therapeutics
VRDN
$3.12B
| $41.5M | 2.86% |
1,924,306
+21,767
|
|
||
|
ZIMV
10
DELISTED
ZimVie
ZIMV
| $39.4M | 2.71% |
2,079,380
|
|
||
|
ABVX
11
Abivax
ABVX
$10.6B
| $36.2M | 2.5% |
+426,499
|
|
||
12
Ionis Pharmaceuticals
IONS
$12.6B
| $35.2M | 2.43% |
538,661
-50,239
|
|
||
13
Revvity
RVTY
$11.4B
| $34.6M | 2.38% |
394,311
-116,019
|
|
||
14
Travere Therapeutics
TVTX
$3.05B
| $33.9M | 2.33% |
1,417,204
+102,171
|
|
||
15
Bio-Techne
TECH
$9.29B
| $32.9M | 2.27% |
591,540
+197,401
|
|
||
16
Celldex Therapeutics
CLDX
$1.86B
| $29.9M | 2.06% |
1,153,920
+315,184
|
|
||
17
Teva Pharmaceuticals
TEVA
$33.1B
| $27.5M | 1.9% |
1,363,653
+310,772
|
|
||
18
Bruker
BRKR
$7.22B
| $22.3M | 1.54% |
687,129
-152,155
|
|
||
19
Community Health Systems
CYH
$467M
| $22.3M | 1.54% |
6,950,051
+805,667
|
|
||
20
UnitedHealth
UNH
$293B
| $21.7M | 1.5% |
62,820
+2,084
|
|
||
|
21
Danaher
DHR
$159B
| $19.7M | 1.36% |
99,273
+75,824
|
|
||
22
Geron
GERN
$785M
| $17.3M | 1.19% |
12,599,002
+5,278,828
|
|
||
23
Elevance Health
ELV
$73.8B
| $14.5M | 1% |
44,980
+26,018
|
|
||
|
24
Insulet
PODD
$20.9B
| $14.1M | 0.97% |
+45,604
|
|
||
25
Repligen
RGEN
$9.16B
| $14M | 0.97% |
105,087
+86,467
|
|